US Stock MarketDetailed Quotes
RAPT RAPT Therapeutics
Watchlist
17.670
+0.760+4.49% Trading 12/06 13:26 ET
17.870High16.675Low224.31KVolume
17.140Open16.910Pre Close3.88MTurnover0.83%Turnover RatioLossP/E (TTM)607.78MMarket Cap31.45052wk HighLossP/E (Static)34.40MShares10.47052wk Low3.52P/B479.78MFloat Cap51.210Historical High--Dividend TTM27.15MShs Float9.855Historical Low--Div YieldTTM7.07%Amplitude17.319Avg Price1Lot Size
About RAPT Therapeutics Company
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolRAPT
Company NameRAPT Therapeutics
Listing Date10/31/2019
Issue Price12.00
Founded2015
CEODr. Brian Russell Wong, PhD
MarketNASDAQ
Employees97
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address561 Eccles Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://rapt.com
Company Executives
- Name
- Position
- Salary
- Dr. Brian Russell Wong, PhD
- President, Chief Executive Officer and Director
- 5.21M
- Dirk G. Brockstedt, PhD
- Chief Scientific Officer
- 713.66K
- Dr. William Ho, PhD
- Chief Medical Officer
- 1.40M
- Rodney Young
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 1.54M
- William J. Rieflin
- Chairman of the Board
- 175.46K
- Dr. Michael F. Giordano, M.D.
- Independent Director
- 141.96K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 152.96K
- Lori Lyons-Williams
- Independent Director
- 136.96K
- Linda Kozick
- Independent Director
- 135.96K
- Dr. Wendye Robbins
- Independent Director
- 140.46K